Inactive Instrument

News Apptix ASA Oslo Bors

Stocks

NO0010123060

Advanced Medical Equipment & Technology

All News

07-13	Carasent (Q2 Review): Positive momentum in several key areas	AQ
07-13	Redeye still sees upside in Carasent after solid Q2 report	FW
07-13	SB1 Markets raises target price for Carasent to 37 kronor (34), reiterates buy	FW
07-13	Carasent: Initiatives in Infosolutions the biggest highlight – Q2 review	AQ
07-10	Carasent (Q2 Initial take): Solid Q2 in line with expectations	AQ
07-10	Carasent AB, Q2 2026 Earnings Call, Jul 10, 2026
07-10	Carasent: Solid report with continued ARR strength – Q2 initial	AQ
07-10	Carasent increases revenue and operating profit	FW
07-10	Carasent () : interim report Q2 2026	PU
07-10	Carasent AB (publ) – interim report Q2 2026	AQ
07-09	Carasent AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-03	Carasent () : Invitation to presentation of Q2 2026 results	PU
07-03	Carasent AB (publ) – Invitation to presentation of Q2 2026 results	AQ
06-24	Carasent: Infosolutions adds another layer to the story – Q2 preview	AQ
06-16	SB1 Markets Initiates Coverage on Carasent with Buy Rating and SEK 34 Price Target	FW
06-09	Carasent completes acquisition of Infosolutions	FW
06-09	Carasent completes the acquisition of Infosolutions	AQ
06-08	Carasent AB (OM:CARA) acquired Infosolutions Sverige Ab for an enterprise value of approximately SEK 120 million.	CI
05-29	Change in the number of shares and votes in Carasent AB (publ)	AQ
05-28	Carasent board member Johan Kallblad acquires shares worth SEK 0.25 million	FW
04-30	EFN issues buy rating on Carasent	FW
04-27	Carasent AB (OM:CARA) agreed to acquire Infosolutions Sverige Ab for an enterprise value of approximately SEK 120 million.	CI
04-27	Carasent: Broadening with lab solution in Sweden	AQ
04-27	Affärsvärlden maintains buy rating on Carasent	FW
04-27	Redeye raises fair value for Carasent to SEK 34 (32)	FW